Dr. Martens plc

Equities

DOCS

GB00BL6NGV24

Footwear

Real-time Estimate Cboe Europe 15:35:39 19/06/2024 BST 5-day change 1st Jan Change
80.9 GBX +0.19% Intraday chart for Dr. Martens plc -4.59% -8.41%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Permira Restructures Dr. Martens Share Ownership MT
Dr Martens says Permira alters shareholding structure AN
Berenberg raises Taylor Wimpey to 'buy' AN
Dr. Martens plc Announces Executive Changes CI
Deutsche Bank Lifts Dr. Martens PT, Keeps Rating at Hold MT
RBC raises Centrica; Citigroup says buy BHP AN
Auto Trader shines thanks to annual results AN
Transcript : Dr. Martens plc, 2024 Earnings Call, May 30, 2024
Jefferies and UBS cut Anglo American AN
Dr Martens promises cost cuts and US reboot as profit drops AN
Auto Trader shines as results impress shareholders AN
FTSE 100 at near one-month low ahead of US inflation data; Anglo drops RE
UK boot maker Dr Martens' new CFO lays out cost-savings plan RE
Dr Martens cuts payout as profit plummets AN
Dr. Martens Posts Lower FY24 Attributable Profit, Revenue MT
Earnings Flash (DOCS.L) DR. MARTENS Reports FY24 Revenue GBP877.1M MT
Tranche Update on Dr. Martens plc's Equity Buyback Plan announced on July 14, 2023. CI
Tranche Update on Dr. Martens plc's Equity Buyback Plan announced on July 14, 2023. CI
Dr. Martens plc Proposes Final Dividend for Fiscal Year Ended 31 March 2024, Payable on 1 October 2024 CI
Dr. Martens plc Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Marathon Partners Calls for Specifics of Dr. Martens' Cost-cutting, Buyback Plans MT
Marathon Partners Urges Dr. Martens to Buy Back Stock CI
Marathon Partners urges Dr Martens to buy back stock, detail expense cuts RE
BAE Systems and Mondi cut to 'neutral' AN
Deutsche Bank Initiates Dr. Martens at Hold MT
Chart Dr. Martens plc
More charts
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA); Americas; and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels, and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion, and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
0.8075 GBP
Average target price
0.7686 GBP
Spread / Average Target
-4.82%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DOCS Stock
  4. News Dr. Martens plc
  5. Marathon Partners Calls for Specifics of Dr. Martens' Cost-cutting, Buyback Plans
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW